Molecule Holdings Inc.
EVRRF
$0.00
$0.000.00%
OTC PK
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.40% | 59.43% | 181.62% | 315.98% | 377.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.40% | 59.43% | 181.62% | 315.98% | 377.53% |
| Cost of Revenue | -6.07% | 27.75% | 113.25% | 205.58% | 229.55% |
| Gross Profit | 35.81% | 12.69% | -41.95% | -104.99% | -89.74% |
| SG&A Expenses | -27.03% | -15.12% | -15.47% | 1.99% | -0.95% |
| Depreciation & Amortization | 89.27% | -10.45% | -74.13% | -80.64% | -82.37% |
| Other Operating Expenses | -- | -- | -- | -- | 100.00% |
| Total Operating Expenses | -16.75% | 3.57% | 23.56% | 48.80% | 37.74% |
| Operating Income | 27.49% | 14.44% | 7.12% | -12.48% | -3.58% |
| Income Before Tax | 11.05% | 20.28% | 23.04% | -3.05% | 31.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.05% | 20.28% | 23.04% | -3.05% | 31.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.05% | 20.28% | 23.04% | -3.05% | 31.47% |
| EBIT | 27.49% | 14.44% | 7.12% | -12.48% | -3.58% |
| EBITDA | 32.34% | 16.71% | 8.18% | -11.12% | 2.25% |
| EPS Basic | 12.22% | 22.06% | 25.69% | 2.19% | 38.17% |
| Normalized Basic EPS | 13.85% | 22.69% | 23.48% | -5.00% | 12.56% |
| EPS Diluted | 12.73% | 16.62% | 20.95% | -3.01% | 34.39% |
| Normalized Diluted EPS | 13.85% | 22.69% | 23.48% | -5.00% | 12.56% |
| Average Basic Shares Outstanding | 1.34% | 2.28% | 3.72% | 5.72% | 9.47% |
| Average Diluted Shares Outstanding | 1.34% | 2.28% | 3.72% | 5.72% | 9.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |